Hussman Strategic Advisors, Inc. Novo Cure LTD Transaction History
Hussman Strategic Advisors, Inc.
- $428 Million
- Q3 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 84,000 shares of NVCR stock, worth $946,680. This represents 0.25% of its overall portfolio holdings.
Number of Shares
84,000Holding current value
$946,680% of portfolio
0.25%Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
281Shares Held
77.1MCall Options Held
943KPut Options Held
155K-
Black Rock Inc. New York, NY12.1MShares$137 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$118 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.9MShares$77.8 Million9.53% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$71.9 Million0.02% of portfolio
-
State Street Corp Boston, MA2.68MShares$30.2 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.18B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...